ImmunoPrecise Antibodies Ltd (IPA)
0.46
-0.02
(-3.62%)
USD |
NASDAQ |
Nov 14, 16:00
0.50
+0.04
(+8.70%)
After-Hours: 20:00
ImmunoPrecise Antibodies Total Liabilities (Quarterly): 19.09M for July 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2024 | 19.09M |
| April 30, 2024 | 19.07M |
| January 31, 2024 | 21.54M |
| October 31, 2023 | 17.05M |
| July 31, 2023 | 17.15M |
| April 30, 2023 | 14.65M |
| January 31, 2023 | 15.96M |
| October 31, 2022 | 15.44M |
| July 31, 2022 | 10.57M |
| April 30, 2022 | 14.19M |
| January 31, 2022 | 6.865M |
| October 31, 2021 | 7.608M |
| July 31, 2021 | 7.212M |
| April 30, 2021 | 8.174M |
| January 31, 2021 | 8.872M |
| October 31, 2020 | 9.476M |
| July 31, 2020 | 10.07M |
| April 30, 2020 | 8.699M |
| January 31, 2020 | 8.408M |
| October 31, 2019 | 8.936M |
| July 31, 2019 | 9.251M |
| April 30, 2019 | 7.724M |
| January 31, 2019 | 6.910M |
| October 31, 2018 | 7.93M |
| July 31, 2018 | 8.931M |
| Date | Value |
|---|---|
| April 30, 2018 | 9.243M |
| January 31, 2018 | 2.381M |
| October 31, 2017 | 2.073M |
| July 31, 2017 | 0.4338M |
| April 30, 2017 | 0.6139M |
| January 31, 2017 | 0.5666M |
| September 30, 2016 | 0.1836M |
| June 30, 2016 | 0.1864M |
| March 31, 2016 | 0.1999M |
| December 31, 2015 | 0.1843M |
| September 30, 2015 | 0.1785M |
| June 30, 2015 | 0.1929M |
| March 31, 2015 | 0.205M |
| December 31, 2014 | 0.2194M |
| September 30, 2014 | 0.2412M |
| June 30, 2014 | 0.2703M |
| March 31, 2014 | 0.26M |
| December 31, 2013 | 0.285M |
| September 30, 2013 | 0.2779M |
| June 30, 2013 | 0.2748M |
| March 31, 2013 | 0.2653M |
| December 31, 2012 | 0.267M |
| September 30, 2012 | 0.2413M |
| June 30, 2012 | 0.2207M |
| March 31, 2012 | 0.2331M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
6.865M
Minimum
Jan 2022
21.54M
Maximum
Jan 2024
12.64M
Average
10.57M
Median
Jul 2022
Total Liabilities (Quarterly) Benchmarks
| Aurinia Pharmaceuticals Inc | 161.36M |
| Edesa Biotech Inc | 2.361M |
| Lexaria Bioscience Corp | 0.2714M |
| Xenon Pharmaceuticals Inc | 39.96M |
| ESSA Pharma Inc | 3.805M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 42.81M |
| Shareholders Equity (Quarterly) | 23.72M |
| Debt to Equity Ratio | 0.0791 |
| Current Ratio | 0.9862 |
| Net Debt Paydown Yield | -1.74% |